[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Pharmacology](https://durgical.com/en/pharmacology/) › [Antimalarials](https://durgical.com/en/pharmacology/classes/antimalarials/) › Tafenoquine

# Tafenoquine

## Antimalarials?

Antimalarials

## Pregnancy: contraindicated?

Contraindicated in pregnancy because it may cause haemolysis in a G6PD-deficient fetus; a pregnancy test is done before use.

Long-acting 8-aminoquinoline, a single dose with chloroquine for P. vivax radical cure; G6PD must be shown normal first.

Updated Nov 1, 2026

## Quick facts

**Group**
[Antimalarials](https://durgical.com/en/pharmacology/classes/antimalarials/)

**Target**
Not fully known: like primaquine, acts on liver hypnozoites and gametocytes

**Used for**
Radical cure · Prophylaxis in travellers

**Key effects**
Nausea · Headache and dizziness · Insomnia

**Monitor**
Quantitative G6PD test before use

**ATC**
P01BA07

No doses: the clinician sets them by the current guideline.

On this page

- The basics Mechanism of action
- Indications
- Adverse effects
- Pharmacokinetics
- Memory aid

- Clinical What the labels mean

- Safety Contraindications
- Key interactions
- What is monitored
- Administration and safety
- Pregnancy and breastfeeding
- Nursing care

- Study Test yourself

- Connections Connections

## Mechanism of action

A derivative of primaquine with presumably the same mechanism: oxidant metabolites kill the dormant liver forms (hypnozoites) of P. vivax and act on other stages. Its main difference is pharmacokinetic: it is absorbed slowly and eliminated over weeks, so one dose replaces a two-week primaquine course for radical cure. Like primaquine, it causes haemolysis in G6PD deficiency.

- Primaquine-like 8-aminoquinoline
- Kills P. vivax liver hypnozoites
- Very long half-life: one dose for radical cure
- Haemolysis if G6PD is deficient

## Indications

- Radical cure (prevention of relapse) of P. vivax malaria, as a single dose together with chloroquine or hydroxychloroquine, in people aged 16 or older [Malaria →](https://durgical.com/en/conditions/malaria/)
- Prophylaxis in travellers (a separate product, for up to six months) [Malaria →](https://durgical.com/en/conditions/malaria/)

## Adverse effects

### Common

- Nausea, vomiting and diarrhoea
- Headache and dizziness
- Insomnia, anxiety, unusual dreams and mood changes
- Blurred vision or light sensitivity; vortex keratopathy
- Raised liver enzymes

### Serious (rare, important)

- Haemolytic anaemia in G6PD deficiency
- Methaemoglobinaemia
- Psychiatric reactions: hallucinations, delusions, psychosis
- Allergic reactions

## Contraindications

- G6PD deficiency or unknown G6PD status
- Pregnancy
- Current or past psychosis or psychotic symptoms
- Hypersensitivity to tafenoquine or primaquine

## Key interactions

**Chloroquine or hydroxychloroquine**
Required partner for radical cure; tafenoquine is used only with them in that indication

**Drugs that cause haemolysis or methaemoglobinaemia (e.g. dapsone, primaquine)**
Additive red-cell toxicity is expected, as with primaquine

## What is monitored

- Quantitative G6PD test before use (qualitative tests can miss intermediate activity in women)
- Pregnancy test before use
- Haemoglobin and urine colour after the dose; effects can appear late because the drug persists
- Mood and behaviour changes

## Administration and safety

- Oral, with food; tablets are swallowed whole, not split, chewed or crushed.
- Given on the first or second day of the chloroquine course.
- If vomiting occurs within an hour of the dose, the prescriber decides whether to repeat it.
- Two products exist for different uses (radical cure, prophylaxis): confirm which one is ordered.

## Pregnancy and breastfeeding

Contraindicated in pregnancy because it may cause haemolysis in a G6PD-deficient fetus; a pregnancy test is done before use.

## Nursing care

- Confirm a normal quantitative G6PD result and a negative pregnancy test before giving it.
- Ask about psychiatric history.
- Teaching: report dark urine, pallor, shortness of breath, blue-grey lips, yellow eyes or hallucinations, even weeks later.
- Contraception during treatment and for about three months after.

## Pharmacokinetics

**Absorption**
Oral, slow (peak about half a day after dosing); taken with food

**Distribution**
Large volume of distribution

**Metabolism**
Not well characterised

**Elimination**
Low clearance, very slow elimination

**Half-life**
About 14 days

## Memory aid

«TAFenoquine: one TAp for vivax»: a single dose, but only after a quantitative G6PD test, and only with chloroquine.

## Test yourself

Think of the answer, then tap the question to see it.

## What is the main advantage of tafenoquine over primaquine?

Its half-life of about two weeks lets a single dose replace a long primaquine course, which improves adherence.

## What test is mandatory before tafenoquine, and why quantitative?

G6PD activity; quantitative tests are needed because qualitative tests can miss intermediate deficiency, which is common in heterozygous women.

## With which drug is it given for P. vivax radical cure?

With chloroquine (or hydroxychloroquine), which treats the blood stage.

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/pharmacology/tafenoquine/)

[More Pharmacology questions →](https://durgical.com/en/practice/?f=pharmacology)

## What the labels mean

**Pregnancy: contraindicated**
Contraindicated in pregnancy because it may cause haemolysis in a G6PD-deficient fetus; a pregnancy test is done before use.

## Connections

## Related drugs 3

- [Primaquine](https://durgical.com/en/pharmacology/primaquine/)
- [Chloroquine](https://durgical.com/en/pharmacology/chloroquine/)
- [Hydroxychloroquine](https://durgical.com/en/pharmacology/hydroxychloroquine/)

## Related conditions 1

- [Malaria](https://durgical.com/en/conditions/malaria/)

[← Back to the class: Antimalarials](https://durgical.com/en/pharmacology/classes/antimalarials/)

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: [Tafenoquine: MedlinePlus Drug Information](https://medlineplus.gov/druginfo/meds/a618050.html) (MedlinePlus (U.S. National Library of Medicine), 2025); [Malaria in the United States: Treatment Tables](https://www.cdc.gov/malaria/hcp/clinical-guidance/appendix-a-treatment-tables.html) (Centers for Disease Control and Prevention (CDC), 2026).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/pharmacology/tafenoquine/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/pharmacology/tafenoquine/
